Fractyl Health Reports Positive 3-Month Reveal-1 Cohort Data
June 23 (Reuters) - Fractyl Health Inc GUTS.O:
FRACTYL HEALTH REPORTS POSITIVE 3-MONTH REVEAL-1 COHORT DATA SHOWING REVITA® SUSTAINED WEIGHT LOSS AFTER GLP-1 DISCONTINUATION, SUPPORTING ITS POTENTIAL AS A FIRST-IN-CLASS WEIGHT MAINTENANCE THERAPY
FRACTYL HEALTH INC - 12 OF 13 PARTICIPANTS MAINTAINED OR LOST WEIGHT AT 3 MONTHS
FRACTYL HEALTH INC - REVITA SHOWS EXCELLENT TOLERABILITY PROFILE COMPARED TO GLP-1 DRUGS
FRACTYL HEALTH INC - RANDOMIZED MIDPOINT COHORT DATA EXPECTED IN Q3 2025
FRACTYL HEALTH INC - MEDIAN WEIGHT REMAINED STABLE THROUGH 3 MONTHS
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
MSTR Stock Price Prediction 2026-2030: Is Strategy the Ultimate Bitcoin Leveraged Play?

SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

Nvidia Stock Prediction: Can NVDA Hit $1,000 by 2030?

Robinhood Slumps 8% After Earnings. Revenue and Profit Both Miss, Market Fears Coinbase May Follow Suit.

Tradingkey







